Pharmaceutical clinical services in basic care in a region of the municipality of São Paulo by Santos, Felipe Tadeu Carvalho et al.
Braz. J. Pharm. Sci. 2018;54(3):e17033 Page 1 / 11
Brazilian Journal of 
Pharmaceutical Sciences
http://dx.doi.org/10.1590/s2175-97902018000317033
A
rt
ic
le
*Correspondência: F. T. C. Santos. Faculdade de Ciências da Saúde, Universi-
dade de Brasília (UnB), Brasília, Brasil, Asa Norte, CEP: 70.910-900, Brasília/
DF. Telefone: 55 11 97981 1400. E-mail: felipescarvalho@yahoo.com.br
Pharmaceutical clinical services in basic care in a region of the 
municipality of São Paulo
Felipe Tadeu Carvalho Santos1*, Dayde Lane Mendonça da Silva2, Noemia Urruth Leão Tavares1,2
1Postgraduate Program in Collective Health, Faculty of Health, University of Brasília (UnB), Brasilia, Brazil, 2Department of 
Pharmacy, Faculty of Health Sciences, University of Brasília (UnB), Brasilia, Brazil
Pharmaceutical care has undergone several transformations in the health context over the years. Thus, the 
pharmacist has suffered a reconfiguration of his performance, mainly with the incorporation of clinical 
services and patient approach. The study analyzed the results of the implementation of pharmaceutical 
clinical services in Primary Health Care, through the use of indicators of supply, demand and productivity, 
clinical and process quality related to pharmaceutical care. We included all the clinical visits (n=1,833) 
performed to 1,080 users in 12 Basic Health Unit facilities from May to November 2016, of which 
40.8% (n=748) were consultations in the establishments and 50.2% (n=1,085) home visits. Most 
patients (73.5%) were referred by team and 17.5% were captured through active search. Of the total 
workload, 12.5%  were dedicated to pharmaceutical consultations and 20.0% to home visits. In total, we 
identified 3,078 pharmacotherapy-related issues, an average of 2.8 per patient, and 6,882 pharmaceutical 
interventions were performed, equivalent to 6.3 interventions per patient. The problem with adherence to 
pharmacotherapy and the intervention of medication counseling were the most found. Results reinforce 
the importance of pharmaceutical clinical services in identifying the control of the most prevalent health 
conditions and monitoring the therapeutic results associated with drug use.
Keywords: Pharmaceutical care/primary care. Chronic health/conditions. Pharmacists/professional 
practice/Brazil.
INTRODUCTION
Pharmaceutical care is an important field in 
the health area and has been mostly understood as a 
bureaucratic management process involving technologies 
aimed at medicines logistics (Araújo, Freitas, 2006). 
The activities related to the clinic and the use of drugs 
are still a challenge for the country, especially regarding 
the performance of the pharmacist in the management of 
patient care with the multiprofessional team.
With the transformations of health technologies and 
services throughout the 20th century, the pharmacist’s role 
and functions have become the focus of intense debate, 
especially in the United States and Europe, with some 
repercussions in Latin America in order to strengthen the 
performance of services provided by this professional 
to the health care network users (Funchal-Witzel et al., 
2011). Roberts et al. (2003) highlights notable changes in 
pharmacy practice with a focus mainly on the provision 
of care services. The pharmacist is even included as a 
professional focused mainly on the performance that 
involves information and training on the use of drugs 
(Loch-Neckel, Crepaldi, 2009).
As described by Oliveira et al. (2005), some studies 
show that an effective performance of the pharmacist with 
the patient and integrated with the health team contributes 
systematically to a more effective drug treatment aiming at 
achieving positive therapeutic results. Despite this, there 
are several barriers to the dissemination of pharmaceutical 
clinical services, which are similar in countries regardless 
of the socioeconomic situation and the developed 
pharmacy model (Gastelurrutia et al., 2005).
Thus, comprehensive care in the complex health 
system, as well as teamwork with an emphasis on the 
Unified Health System (SUS) address the social needs of 
the pharmacist in today’s society. This professional then 
begins to incorporate new care strategies into his work 
routine by developing clinical services offered to the 
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population, through the development of user counseling 
actions, pharmacotherapy review, drug reconciliation, 
evaluation and promotion of therapeutic adherence and 
pharmacotherapeutic follow-up (Brasil, 2014a). These 
actions are materialized through the realization of specific 
and shared consultations, home visits and educational 
actions geared to the community, which occur mainly in 
the scope of primary health care.
In view of the above, the development of studies that 
show the impact of pharmaceutical clinical consultations 
on public health, targeting various lines of care developed 
in primary health care (PHC) and people’s quality of 
life is gaining significance. This study aimed to analyze 
the preliminary results of the implementation of clinical 
services performed by pharmacists in PHC in a region 
of the city of São Paulo, using supply, demand and 
productivity indicators of these services, as well as process 
indicators and clinical indicators that evidence patients’ 
health conditions.
METHODOLOGY
This is a retrospective descriptive study with a 
quantitative methodological approach in which data from 
clinical consultations performed by pharmacists working 
in 12 PHC with the Family Health Strategy (ESF) 
modality of the Eastern Regional Health Coordination, 
in the Technical Health Supervision of the Itaim 
Paulista region in the municipality of São Paulo, which 
implemented pharmaceutical clinical services during the 
study period.
The Itaim Paulista region is located in the extreme 
east of the city of São Paulo and consists of a total of 
approximately 380,000 inhabitants, according to the 2010 
Census (São Paulo, 2016a). It is one of the most populous 
regions of the city, has a low level of family income, with 
a predominance of up to two minimum wages, as well as 
a low schooling population profile (Varela, Matsumoto, 
2012). Overall, 19 pharmacists work in PHC services. 
Regarding health equipment, it has 15 UBS, of which 12 
are of the ESF modality, as well as a health surveillance 
center, three Psychosocial Care Centers (CAPS) and 
three urgent and emergency care facilities. It also has two 
physical rehabilitation centers and one day-hospital, called 
Rede Hora Certa, as well as one medium-sized regional 
hospital. (São Paulo, 2016b).
The pharmaceutical clinical services investigated 
were implemented and institutionalized based on a 
project conducted by the Santa Marcelina Social Health 
Organization in partnership with the Itaim Paulista Health 
Technical Supervision in the year 2016, which included 
the training and follow-up of pharmacists in the territory. 
Each UBS has a pharmacist with a workload of 40 hours 
of work a week.
We included in the study data from all pharmaceutical 
clinical services performed through consultations and 
home visits at the UBSs that implemented clinical 
services in the period from May 2 to November 30, 2016, 
which correspond to the first seven months of service 
implantation in the PHC of the region, being therefore 
preliminary data of the study.
Patient eligibility criteria for pharmaceutical clinical 
service in the region were defined jointly with the health 
team: use of 5 or more drugs, having two or more chronic 
comorbidities and a suspected pharmacotherapy-related 
problem. Any professional could make the referral of 
the user to the pharmaceutical service, according to 
established criteria.
The variables used to characterize the profile of the 
users served in the pharmaceutical clinical services were: 
sex (male or female), age range (between 0 and 20, 20 
and 40, 40 and 60, over 60 years), use of alcoholic drink 
(yes or no), use of tobacco currently (yes or no), perform 
some physical activity (yes or no), difficulty in using 
medications (yes or no) and has a caregiver (yes or no).
Services performed for patients who moved to 
another area, that is, UBS of reference, during the 
defined period for data collection were excluded from 
the analysis, as were consultations and home visits 
performed for patients who died or abandoned the service 
(care refusal).
The service database used a data collection 
source, which consolidated the information from the 
pharmaceutical services with data from the programmed 
schedule of the professional, the production sheet and 
clinical care records. Consultation forms and home visits 
were used (Brasil, 2014b). 
Indicators related to supply, demand and productivity 
of services as described in Figure 1 were built for the 
analysis of pharmaceutical clinical services.
As a complement, we analyzed during the study 
period process and clinical indicators of consultations 
performed, according to Figure 2. Pharmacotherapy-
related problems were identified through the patient’s 
anamnesis and pharmacotherapy review, in which real 
or potential drug-related problems were identified, 
and the following pharmacotherapy-related groups of 
problems categorized from the services were considered 
in the analysis according to the classification used in 
the Pharmaceutical Care Project in Basic Health Care 
of the Health Ministry (Brasil, 2014b), in: problems 
related to drug selection and/or prescription, problems 
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of administration and/or adherence by the patient to 
pharmacotherapy, problems of drug discrepancy between 
levels of care, problems in dispensing the medication, 
problems in monitoring the health condition and that 
involve drug safety (adverse reaction and poisoning).
Interventions were considered to be the conduct 
performed by pharmacists at each clinical care, such 
as advice on medications or non-pharmacological 
measures, drug therapy change or suggested change, 
recommendation for monitoring to assess the clinical 
FIGURE 1 - Indicators related to supply, demand and productivity of pharmaceutical clinical services in PHC.
FIGURE 2 - Process and clinical indicators of patients seen in clinical pharmaceutical services of Primary Health Care.
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status of patients’ health conditions, referrals to others 
professionals and provision of materials for dosage 
orientation (Brasil, 2014b). 
Indicators (Figure 2) of hypertensive and diabetic 
users, as verified by the patient’s diagnosis in the medical 
records due to the prevalence of such health conditions 
were analyzed to assess the control profile of the clinical 
status of health conditions of patients treated in the first 
three months of the implementation of pharmaceutical 
clinical services.
The evaluation performed at the clinic took into 
consideration the clinical and laboratory parameters, 
such as residential blood pressure, capillary glycaemia 
and glycated hemoglobin monitoring, according to 
hypertension and diabetes protocols and clinical guidelines 
(Sociedades Brasileiras de Cardiologia, Hipertensão 
e Nefrologia, 2011; Sociedade Brasileira de Diabetes, 
2015). Thus, patients were categorized by scope of the 
established therapeutic goals, in: controlled, when goals 
were achieved at that moment; non-controlled, indicating 
that problem is not under control and non-achievement of 
therapeutic goals; and unknown, where, due to the lack 
of clinical and laboratory parameters, it was not possible 
to define the comorbidity control profile at that moment.
The analysis of the results was performed by 
descriptive statistical inference, where measures of central 
tendency and variability and simple and relative absolute 
frequencies, supported by the system for statistical 
analyzes of the Epi Info™ 7.1.5 program were calculated. 
Access to the database was made available through 
authorization by the competent authority of the Municipal 
Health Secretariat of São Paulo and information was 
aggregated without individual identification. According 
to Resolution Nº 510/2016, it was exempted from the 
evaluation of the Research Ethics Committee (CEP).
RESULTS
We analyzed data on consultations and home visits 
performed by pharmacists in 12 UBS that implemented 
the clinical services during the study period. In this 
time bracket, 1,080 users were attended, totaling 1,833 
visits, of which 40.8% (n=748) were consultations in 
health facilities and 59.2% (n=1,085) were home visits. 
Of the total number of attendances, a large part (59%) 
corresponded to first-time attendance and the other to 
returning visits, which ranged from one to six returning 
visits in the period.
Females were the predominant profile of users 
serviced in pharmaceutical clinical services, with 71% 
(n=767), and 60 years and over, with 63% (n=681). Of 
the total, 92% (n=994) reported not having consumed 
any type of alcoholic beverages, 86% (n=929) were not 
smokers and only 12% (n=130) exercised at least three 
times a week in the care period. While 40% (n=432) had 
difficulty in conducting drug treatment autonomously, 
only 21% (n=227) had a caregiver for health care and drug 
administration assistance.
Regarding the profile of pharmacists, all the 
participants worked in a UBS with a 40-hour weekly 
workload. In the implementation of the service, the 
pharmacist’s activities were distributed in a fixed weekly 
schedule, standardized in all facilities, where 40.0% 
(n=16) of the workload was logistical and administrative 
activities, 42.5% (n=17) clinical assistance activities and 
17.5% (n=7) technical-pedagogical activities of interaction 
with the team and meetings. It is worth mentioning that, in 
addition to the consultations and home visits, other care 
activities were planned in the agenda, such as educational 
groups and reception of users.
Regarding supply indicators, of the pharmacist’s 
weekly workload (40 hours), 5 hours were allocated for 
consultations and 8 hours for home visits, corresponding 
to 12.5% and 20.0% of the workload, respectively. 
Analyzing productivity, an average of 11.9 pharmaceutical 
consultations per month were performed in each facility, 
both specific and shared with other professionals. The 
average number of consultations was 19.5 per month, 
with an absenteeism rate of 39.2% (n=1,230). As for home 
visits, an average of 19.5 visits were scheduled per month, 
with around 17.2 visits/month and 11.5% of scheduled 
home visits were not performed because the patient was 
not at home at the time of the visit or refused care.
Regarding the identification of users serviced at 
pharmaceutical clinical services, which represents the 
demand indicator, approximately 73.5% (n=794) were 
referred by the health team, mainly doctors and nurses, 
17.5% (n=189) were captured through active search 
of the pharmacist or pharmacy technician, based on 
previously established criteria, and only 9.0% (n=97) 
originated from self-referrals, that is, people themselves 
sought the service.
During the study period, 3,078 pharmacotherapy-
related problems were identified in 1,080 users, equivalent 
to 2.8 problems per patient. The most frequent problem 
was non-adherence to pharmacotherapy, mainly regarding 
the omission of doses and administration of medication at 
incorrect frequency.
From the identification of drug-associated problems, 
pharmaceutical interventions were carried out, which 
encompass the professional conduct before a diagnosis 
or evaluation and aimed to achieve the therapeutic goals 
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and the prevention, identification and resolution of 
pharmacotherapy-related problems. Such interventions 
may be associated with specific guidelines on the drug, 
as well as referrals to other professionals, use of dosage 
guidance tools and specific treatment adaptations. A total 
of 6,862 interventions were performed on 1,080 patients, 
that is, 6.3 interventions per patient. A relationship 
with several interventions was standardized, allowing a 
quantitative survey on interventions, and the advice to 
the patient on drug treatment and non-pharmacological 
measures were the most recurrent, in 85.8% of users.
The evaluation of the clinical status of the most 
prevalent chronic conditions identified in the first, second 
and third pharmacological care was performed as a way 
of evaluating the therapeutic results that may be related to 
the use of drugs, as can be observed in Tables I and II. It is 
worth mentioning that hypertension and diabetes mellitus 
were the most frequent morbidities among patients treated 
at pharmaceutical services, with a rate of 80.1% (n=865) 
and 58.6% (n=633) of the patients, respectively.
DISCUSSION
The organization of the pharmacist’s work through a 
model of an activity distribution agenda that contemplates 
the logistic-administrative and also assistance realms, 
as presented in the study, with a fair workload for each 
of these realms allows the development of a care model 
focused on the individual rather than on the product, as 
recommended by the National Pharmaceutical Assistance 
Policy (Brasil, 2004). The agenda with distribution 
of professional hours is an interesting alternative for 
the organization and linkage of pharmaceutical work, 
given the different demands and attributions under the 
responsibility of this professional.
Veber (2005) and Foppa et al. (2008) corroborate the 
incorporation of the pharmacist into PHC through actions 
geared to drugs, users and other health professionals, in 
order to contribute to an effective and safe drug treatment, 
reaffirming the importance of measuring these three 
instances of action in the pharmacist’s routine. Araújo et 
al. (2008) and Araújo and Freitas (2006) discuss activities 
aimed at drug management as being more predictable and 
repetitive, in addition to being more associated with legal 
aspects, whereas actions directed at users encompass 
a direct integration with the patient and through the 
involvement with other health professionals, in which 
the main focus are the results deriving from the use of 
pharmacotherapy.
Among the care activities planned in the agendas of 
the pharmacists of the study, we highlight pharmaceutical 
consultations and home visits, which were used as supply 
indicators variables for the pharmaceutical clinical 
services of the territory. Five weekly hours were foreseen 
for pharmaceutical consultations and eight weekly hours 
for home visits, equivalent to 12.5% and 20% of the total 
workload, respectively. This supply pattern was used by 
all facilities, regardless of the complexity of the service 
and teams’ size. However, this would be adapted after a 
period of evaluation by the local managers of each facility. 
The pharmacist’s work with users is pointed out as 
an important strategy for the resolution of PHC and the 
promotion of the rational use of drugs. Soler et al. (2010) 
state that the pharmacist’s clinical involvement supports 
and cooperates with health promotion and prevention 
actions. However, while the presence of the pharmacist in 
TABLE I - Proportion of arterial hypertension control in the first, second and third pharmaceutical care in the city of São Paulo 
from May to November 2016
Clinical control profile % first care (n=865) % second care (n=442) % third care (n=109)
Controlled 10.1 39.1 50.5
Non-controlled 16.3 29.9 31.2
Unknown 73.6 31.0 18.3
TABLE II - Proportion of Diabetes Mellitus control in the first, second and third pharmaceutical care in the city of São Paulo from 
May to November 2016
Clinical control profile % first care (n=633) % second care (n=346) % third care (n=89)
Controlled 5.5 24.3 25.8
Non-controlled 31.0 52.0 65.2
Unknown 63.5 23.7 9.0
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PHC is already a reality in the country, the development 
of technical activities aimed at drug logistics and supplies 
availability (Canto, 2016) is still predominant. In a survey 
carried out in the south of the country with pharmacists 
working at the Family Health Support Center (NASF) in 
2013, it was identified that 80% of the pharmacist’s total 
workload was focused on administrative activities and a 
small portion on care activities (Brasil, 2014c).
Within the scope of the Municipal Health Secretariat 
of São Paulo, Ordinance Nº 1918/2016 establishes some 
guidelines that guide PHC pharmacists’ need to distribute 
their activities, so as to reconcile clinical and care and 
logistic actions, but there is no standard agenda model for 
the different care modalities nor specific parameters that 
support the distribution of the workload of pharmacist’s 
activities in this level of health care (São Paulo, 2016c).
The introduction of the pharmacist in the context 
of PHC has been configured in order to build an identity 
based on new practices that transcend the availability 
of the pharmacological supplies and whose basic and 
essential foundation is reduced morbidity and mortality 
risks and the rational use of drugs. The setting of healthy 
public policies and the establishment of favorable 
promotional environments thus require professional 
skills, including in the pharmaceutical area, which exceed 
technical capacity, but which must also be political and 
understand all inherent aspects of human beings (Leite, 
2007; Vieira, 2007).
From the data of the pharmaceutical services 
evaluated, we can infer that the greater number of home 
visits is due to the configuration of the pharmacist’s 
agenda, which foresees a greater offer of this type of 
activity to the detriment of the consultations scheduled at 
the health facilities. One of the technologies for interaction 
in health care, mainly used in PHC, is home visit, which 
prioritizes the diagnosis of the individual’s reality and 
the development of educational actions, through the 
establishment of links and by understanding the important 
aspects of the dynamics of family relationships, which 
directly influence the individual illness process. Thus, 
home care is a fundamental intervention tool in the context 
of family health and is included in the programmatic 
agenda of professionals working in the ESF, in order to 
subsidize interventions and the planning of health actions 
according to the way of life and resources available in the 
territory (Foppa et al., 2008; Albuquerque, Bosi, 2009; 
Giacomozzi, Lacerda, 2006).
Another highlight is the rate of first-time and return 
visits. The size of these services may vary according 
to some variables, such as: users’ profile on the need 
for a short-term return, according to the care plan 
elaborated in the first attendance, recent incorporation 
of clinical pharmaceutical services in the territory and 
the evaluation period. As planned in the agenda, each 
first-time pharmaceutical appointment had an average 
duration of one hour and a return of 40 minutes, whereas 
home visits were scheduled at 1 hour per patient. Thus, 
each pharmacist had a weekly program of at least 5 
consultations and 8 home visits, which were scheduled 
in advance with the team. This was the standard scope 
of pharmaceutical agenda in the territory, but the number 
of patients scheduled for first time and return visits 
was different between facilities and depended on local 
management, according to the aforementioned variables.
With respect to absenteeism in the pharmaceutical 
consultations, it indicates the non-attendance of 
approximately 4 out of 10 scheduled patients. Santos 
(2008) states that the estimate of the absenteeism rate in 
procedures and consultations in the SUS ranges from 22 
to 30%. However, in a study conducted in João Pessoa/
PB, where the absenteeism rate in some UBS with ESF 
(n=26) of a district was evaluated, the percentage of non-
attendance in consultations in the facilities ranged from 
24% to 41% (Cavalcanti et al., 2013). It is important to 
critically assess the absenteeism rate per facility, since it is 
multi-causal and may be related to territory characteristics, 
as well as to the linkage of the population with the facility 
and health professionals. In the case of pharmaceutical 
consultations, absenteeism may be related to the type 
of service offered, the acceptance and sensitization of 
the population, the effectiveness of the service itself and 
especially the recent onset of supply of pharmaceutical 
consultation services in the territory.
The rate of non-performance of scheduled home 
visits is lower than that of absenteeism in the consultations 
and is mainly related to the resident’s absence at the time 
of the visit. Generally, the pharmacist is accompanied by 
the community health worker, who already has a link with 
the population and knows the routine of the community, 
favoring the accomplishment of visits. Some important 
strategies for the reduction of absenteeism in EFS have 
been listed, such as prior notice by the community worker 
and the telephone contact to confirm care (Ferreira et al., 
2016a; Cavalcanti et al., 2013). In addition, it is worth 
mentioning the need to establish parameters that define 
acceptable limits of absenteeism in the national health 
policy in order to contribute to a better monitoring and 
evaluation of this event (Cavalcanti et al., 2013).
With regard to the listed demand indicator, which 
portrays the identification of users for pharmaceutical 
clinical care, a large portion was referred by the team 
and 17.5% resulted from active search. In a study carried 
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out in the city of Curitiba, the capture of patients for 
the pharmaceutical consultation from the referral of 
other professionals was 55.6%, while active search had 
a rate of 43.6% in the first three months of the onset of 
pharmaceutical consultations (Brasil, 2014c). Hence, 
it is possible to demonstrate good acceptance of the 
pharmaceutical clinical services by the other professionals 
of the health team in order to show the possibility of an 
integrated and resolutive work. However, it is worth noting 
that before the start of the pharmaceutical consultations 
in the evaluated region, all facility professionals were 
sensitized, in addition pharmacists participate daily in 
team meetings to discuss and provide feedback on the 
referred cases. These factors may also justify the fact that 
almost all the vacancies of pharmaceutical consultations 
supplied (20 hours consultations/month) were fully 
booked, some 19.5 hours scheduled consultations/month, 
which shows a demand for this type of service.
However, this is not the case with pharmaceutical 
home visits, since 32 hours of visits/month were offered 
and only 19.46 hours of visits/month were filled. 
Giacomozzi and Lacerda (2006) describe that some 
difficulties related to the implementation of home care in 
the ESF are mainly due to the supply structure and also to 
professional training. We can think of a possible difficulty 
of securing patients by the pharmacist for this type of 
service, which may be associated both to the team and to 
specific questions of the pharmaceutical professionals, 
such as insecurity as to the development of this type of 
activity, deficient training and even difficulty in untying 
pharmacy’s physical space in the facility, which makes it 
hard to leave the room for visits in the territory.
The matrix support and the incorporation of an 
inclusive stance of the pharmacist with the team in 
the shared responsibility of patients are fundamental 
processes. The pharmacist often faces hardships in 
inserting and integrating with the team in PHC, because 
he cannot clearly understand his duties in this context, 
thus generating a professional insecurity in the area of 
operation, which impairs the consolidation of his work 
and the recognition of his activities (De Castro, Quevedo, 
2014).
The profile of patients who underwent clinical 
pharmacological care during the study period was mostly 
female over 60 years of age. In addition, according to 
priority criteria established for referral to the pharmacist, 
they used five or more medications and had two or more 
chronic comorbidities. This profile characterizes users 
who use health services more frequently and are subject 
to more vulnerable situations caused by medications or 
worsening of chronic conditions.
It is worth noting that the profile of an elderly user 
necessarily has greater difficulties in the use of drugs (Field 
et al., 2007), as evidenced in the study, in which 40% of the 
patients had no autonomy in the administration of drugs 
due to potential weaknesses related to sensory and memory 
organs. Nevertheless, only 21% of users have a health care 
caregiver, which may directly interfere with the results 
of pharmacotherapy. Studies indicate that it is common 
to identify problems associated with medications in the 
elderly, especially regarding inappropriate prescriptions 
in basic care, contributing to the increase of hospital 
admissions (Riordan et al., 2016).
The development of clinical services is primarily 
aimed at improving the results from the use of a drug 
therapy, from the prevention, identification and resolution 
of drug-related problems through the implementation of 
pharmaceutical interventions that may be associated to 
the patient or to another healthcare professional. Hence, 
it is fundamental to understand pharmacotherapy-related 
processes, ranging from the selection of pharmacological 
treatment to the manifestation of therapeutic results in the 
body (Foppa et al., 2008; Correr, Otuki, 2013).
With reference to service process indicators, the 
identification of pharmacotherapy-related problems is 
part of the evaluation scope of the pharmacist who, from 
the patient’s anamnesis and pharmacotherapy review 
identifies the real or potential problems associated with 
the drug (Correr, Otuki, 2013; Brasil, 2014b). We found 
an average of 2.85 pharmacotherapy-related problems 
per patient in the study period, and the predominant user-
related problem was non-adherence to drug treatment.
In a study carried out in Goiânia with hypertensive 
patients, we identified 10.1 drug-related problems per 
patient, and the most recurrent problem was ineffective 
treatment, and non-adherence was only the fourth 
most common issue (Martins et al., 2013). In a study 
conducted by Alano, Correa and Galato (2012) with 
patients monitored in a pharmaceutical care service of 
Santa Catarina, an average of 2.7 problems per patient 
were identified and the most common were related to 
the drugs’ effectiveness and safety. Thus, it is possible to 
perceive that the proportion of pharmacotherapy-related 
problems per patient is variable, since it depends on the 
selection criteria of patients and their characteristics, the 
number of medications used and the methodology for 
quantifying the types of problems. However, some studies 
have shown that the use of a greater number of drugs leads 
to a higher frequency of errors of users related to their 
pharmacotherapy (Field et al., 2007).
An average of 6.35 pharmaceutical interventions per 
patient was performed and counseling was predominant. 
F. T.C. Santos, D. L. M. Silva, N. U. L. Tavares
Braz. J. Pharm. Sci. 2018;54(3):e17033Page 8 / 11
As in other studies, verbal pharmaceutical orientation 
mainly related to drug treatment is the most recurrent 
in pharmaceutical clinical care (Martins et al., 2013; 
Ferreira et al., 2016b). Patients’ lack of knowledge 
about the medications used may result in poor adherence 
and negative therapeutic outcomes, so pharmaceutical 
counseling becomes critical for users’ empowerment 
regarding their medications and greater pharmacotherapy 
success (Oenning, Oliveira, Blatt, 2011). Studies have 
shown that the elderly usually receive the highest number of 
pharmaceutical interventions in clinical care (Ferreira et al., 
2016b), probably due to possible complexities in treatment, 
such as high number of medications and comorbidities.
PHC is fundamental since it is the main gateway 
to the state health care system in our country, it thus 
plays a relevant role in responding to a large part of 
the population’s demand. In Brazil, about 60 to 80% 
of hypertension and diabetes cases can be treated and 
prevented at this level of care. From then on, it is possible 
to perceive the effective resolution capacity of this PHC, 
defined as a technologically specific form of health care, 
establishing itself through the synthesis of knowledge and 
complex integration of individual and collective actions, 
with curative, preventive, care-related and educational 
purposes (Araújo, Pereira, Freitas, 2008; Pereira, Freitas, 
2008; Carvalho et al., 2012).
In this perspective, the control profile of the most 
prevalent chronic health conditions was evaluated in the 
patients who underwent pharmaceutical care, as a way of 
evidencing the therapeutic results that may be related to the 
use of drugs and resolution of the clinical services provided 
to the population. The most frequently diagnosed chronic 
conditions were hypertension and diabetes mellitus, due 
to the type of patient attended and the prevalence of these 
diseases in society. Control parameters were observed 
based on the definition of therapeutic goals, due to the 
established clinical protocols, and the accomplishment of 
laboratory tests and clinical monitoring.
It is interesting to note that the first pharmaceutical 
care is characterized by a high rate of lack of knowledge of 
therapeutic results of chronic comorbidities hypertension 
and diabetes due to the lack of clinical parameters and 
laboratory tests that attest the current clinical status of 
these problems. The increasing number of treatments 
reduces the unknown clinical status and increases the 
controlled and non-controlled parameters, probably due 
to the effectiveness of pharmaceutical intervention related 
to the recommendation to monitor blood pressure and 
blood glucose.
A study carried out in Curitiba also showed 
a considerable number of patients who, in the first 
pharmaceutical care, have unknown therapeutic results 
regarding their health conditions, namely, about 57% 
of hypertensive patients and 31% of diabetics (Brazil, 
2014c). The therapeutic goal to be achieved is always the 
compensation of the patient, that is, achieving the ideal 
clinical indicators established for each health condition 
and to keep the patients in a controlled clinical status. 
However, it is important to emphasize that achieving 
positive therapeutic results, especially with regard to 
chronic comorbidities, also involves non-drug parameters 
such as healthy lifestyle habits, which should also be 
worked by pharmacists and other team members with 
the patient. Results demonstrate the importance of 
pharmaceutical clinical services in achieving concrete 
results for the health indicators of the population.
Studies have shown an important contribution of the 
pharmacist with regard to the care associated with chronic 
diseases, mainly regarding the improvement of the self-
management of medications, resulting in improvements 
in the chronic health conditions of hypertensive and 
diabetic patients, as well as with psychiatric comorbidities 
(Dolovich et al., 2008; Rotta et al., 2015).
Thus, pharmacists play an important role in working 
jointly with the PHC team, promoting a rational use of 
pharmacotherapy, as well as contributing to effective 
and safe results in the use of medicines aimed at health 
conditions and comorbidities more frequent in the 
community (Alano, Correa, Galato, 2012; Martins et al., 
2013).
CONCLUSIONS
The implementation of an agenda, which allows 
the proper sizing of pharmaceutical activities’ workload 
according to local needs and the characteristics of the health 
facility enables the reorganization of the work process of 
this professional, in order to add logistic-administrative and 
clinical-care actions, which focus not only on the drug, but 
also on patients and other professionals.
There is evidence of a good team acceptance 
regarding the development of pharmaceutical clinical 
services in the facilities, since most patients attended 
in the pharmaceutical consultations and home visits 
were referred by other health professionals. In this same 
perspective, all vacancies for pharmaceutical consultations 
supplied were practically filled, demonstrating a balance 
between supply and demand of this activity, which was 
not case of home visits, due to fewer scheduled visits 
against vacancies available. The rate of absenteeism in 
pharmaceutical consultations is a relevant problem that 
must be managed in the service analysis process.
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Among the pharmacotherapy-related problems 
identified in pharmaceutical consultations, the most 
frequent was non-adherence to drug treatment, and, 
consequently, advice on pharmacotherapy and healthy life 
habits was the most frequent pharmaceutical intervention 
performed on patients. Patient follow-up through 
consultations and home visits to pharmaceutical products 
contributed to a better understanding of the control profile 
of the most prevalent health conditions and the gradual 
development of therapeutic results associated with the 
use of drugs.
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